Cargando…
Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
Sarcopenia in patients with liver cirrhosis (LC) has been attracting much attention these days because of the close linkage to adverse outcomes. LC can be related to secondary sarcopenia due to protein metabolic disorders and energy metabolic disorders. LC is associated with profound alterations in...
Autores principales: | Nishikawa, Hiroki, Enomoto, Hirayuki, Nishiguchi, Shuhei, Iijima, Hiroko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432211/ https://www.ncbi.nlm.nih.gov/pubmed/32722100 http://dx.doi.org/10.3390/ijms21155254 |
Ejemplares similares
-
Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021) -
Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2021) -
Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021) -
Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies
por: Enomoto, Hirayuki, et al.
Publicado: (2020) -
Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study
por: Nishikawa, Hiroki, et al.
Publicado: (2021)